Systematic Review and Meta-Analysis of Damage Associated Molecular Patterns HMGB1 and S100B in Schizophrenia
Michael Mackey, Laurena Holleran, Gary Donohoe, Declan P. McKernan
Psychiatry Investig. 2022;19(12):981-990.   Published online 2022 Dec 22     DOI:
Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs
Miriam Ouadih-Moran, Antonio Muñoz-Hoyos, Luis D’Marco, Antonio Molina-Carballo, Isabel Seiquer, Ana Checa-Ros
Nutrients.2023; 15(3): 712.     CrossRef
Biochemical and Anthropometric Parameters for the Early Recognition of the Intrauterine Growth Restriction and Preterm Neonates at Risk of Impaired Neurodevelopment
Maria Cristina Aisa, Benito Cappuccini, Alessandro Favilli, Alessandro Datti, Vincenza Nardicchi, Giuliana Coata, Sandro Gerli
International Journal of Molecular Sciences.2023; 24(14): 11549.     CrossRef
Mini review: Current status and perspective of S100B protein as a biomarker in daily clinical practice for diagnosis and prognosticating of clinical outcome in patients with neurological diseases with focus on acute brain injury
Tammam Abboud, Veit Rohde, Dorothee Mielke
BMC Neuroscience.2023;[Epub]     CrossRef